KAR House Residential Substance Abuse Program

Located in Wichita, KS, KAR House Residential Substance Abuse Program operates within the KS regulatory framework as a licensed addiction-treatment provider. The facility provides residential + detox programming (28–90 days of 24/7 care) without a full outpatient step-down. Structural evaluation of this facility's clinical posture requires review of state licensing records, accreditation status, and payer-network contracts.

Care levels at KAR House Residential Substance Abuse Program

KAR House Residential Substance Abuse Program operates as a residential facility with detox on-site. Patients leaving here typically transition to outpatient treatment elsewhere, which makes aftercare planning a meaningful part of the admission conversation. ASAM Criteria 4e level-of-care matching requires clinical assessment across six dimensions (withdrawal potential, biomedical conditions, emotional/behavioral/cognitive conditions, readiness, relapse risk, recovery environment). The alignment of KAR House Residential Substance Abuse Program's offerings to any specific patient's clinical profile should be determined by an independent ASAM-aligned assessment prior to admission.

Insurance and payment

Payment and insurance specifics for KAR House Residential Substance Abuse Program are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. Benefit verification should be obtained in writing prior to admission and should document: network contract status for the specific insurance product, prior authorization requirements and approved day-count, applicable cost-sharing structure, and out-of-network secondary coverage (where applicable). Proceeding on verbal VOB creates material risk of post-admission benefit dispute.

Before you call

Operational admission checklist for KAR House Residential Substance Abuse Program: (a) clinical assessment with documented ASAM 4e level-of-care recommendation; (b) insurance benefits verification in writing; (c) MAT policy documentation; (d) accreditation and licensure verification; (e) confirmed prior authorization for specific level of care. Each should be obtained in written form prior to admission. If the clinical situation involves opioid use disorder, confirm explicitly whether KAR House Residential Substance Abuse Program offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.